The initially reported sensitivity for [68Ga]Ga-PSMA-11 for primary diagnosis in intermediate- or high-risk PCa ranged from 40% to 93%, while the specificity was consistently high (between 88% and 99%) [64,65,66,67,68,69,70,71,72]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.